Koduru P - Search Results

1

Multicystic Clear Cell Renal Tumors With Low-grade Nuclear Features: Time to Include TFE3 Translocation-associated Carcinomas.

Cai Q, Gagan J, Koduru P, Cadeddu J, Shah RB, Kapur P, Palsgrove DN. Cai Q, et al. Among authors: koduru p. Adv Anat Pathol. 2024 Jan 1;31(1):34-42. doi: 10.1097/PAP.0000000000000420. Epub 2023 Nov 6. Adv Anat Pathol. 2024. PMID: 37937590

2

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.

Langer C, Radmacher MD, Ruppert AS, Whitman SP, Paschka P, Mrózek K, Baldus CD, Vukosavljevic T, Liu CG, Ross ME, Powell BL, de la Chapelle A, Kolitz JE, Larson RA, Marcucci G, Bloomfield CD; Cancer and Leukemia Group B (CALGB). Langer C, et al. Blood. 2008 Jun 1;111(11):5371-9. doi: 10.1182/blood-2007-11-124958. Epub 2008 Mar 31. Blood. 2008. PMID: 18378853 Free PMC article. Clinical Trial.

3

Distinct mutational and clinicopathologic profiles characterize acute myeloid leukemia with cup-like nuclei.

Oertling E, Fuda F, Koduru P, Chen M, Weinberg O, Juntilla M, Jaso J, Vusirikala M, Chung S, Geethakumari PR, Madanat YF, Collins R, Gagan J, Chen W. Oertling E, et al. Among authors: koduru p. Leuk Res. 2023 Jan;124:106995. doi: 10.1016/j.leukres.2022.106995. Epub 2022 Nov 25. Leuk Res. 2023. PMID: 36459761 No abstract available.

4

Adenoid Cystic Carcinoma With Striking Tubular Hypereosinophilia: A Unique Pattern Associated With Nonparotid Location and Both Canonical and Novel EWSR1::MYB and FUS::MYB Fusions.

Weinreb I, Rooper LM, Dickson BC, Hahn E, Perez-Ordonez B, Smith SM, Lewis JS Jr, Skalova A, Baněčková M, Wakely PE Jr, Thompson LDR, Rupp NJ, Freiberger SN, Koduru P, Gagan J, Bishop JA. Weinreb I, et al. Among authors: koduru p. Am J Surg Pathol. 2023 Apr 1;47(4):497-503. doi: 10.1097/PAS.0000000000002023. Epub 2023 Mar 15. Am J Surg Pathol. 2023. PMID: 36920022

5

Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype.

Zheng R, Fuda F, Gagan JR, Weinberg OK, Koduru P, Cantu M, Ludwig K, Truscott JM, Collins R, Chung S, Madanat YF, Chen W. Zheng R, et al. Among authors: koduru p. Leuk Res Rep. 2023 Dec 31;21:100410. doi: 10.1016/j.lrr.2023.100410. eCollection 2024. Leuk Res Rep. 2023. PMID: 38273970 Free PMC article.

6

RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies.

Koduru P, Chen W, Fuda F, Kaur G, Awan F, John S, Garcia R, Gagan J. Koduru P, et al. Clin Pathol. 2024 Feb 16;17:2632010X241230262. doi: 10.1177/2632010X241230262. eCollection 2024 Jan-Dec. Clin Pathol. 2024. PMID: 38371338 Free PMC article.

7

Retroperitoneal Sarcomatoid Yolk Sac Tumor in a Chemotherapy-Naive Patient With Testicular Postpubertal Type Teratoma: A Rare Case Report With Emphasis on Molecular Features.

Zhang B, Kapur P, Koduru PR, Jia L. Zhang B, et al. Among authors: koduru pr. Int J Surg Pathol. 2024 Feb 20:10668969241231973. doi: 10.1177/10668969241231973. Online ahead of print. Int J Surg Pathol. 2024. PMID: 38377960

8

T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation.

Botten GA, Zhang Y, Fuda F, Koduru P, Weinberg OK, Slone TL, Zheng R, Dickerson KE, Gagan JR, Chen W. Botten GA, et al. Among authors: koduru p. Br J Haematol. 2024 Feb 22. doi: 10.1111/bjh.19363. Online ahead of print. Br J Haematol. 2024. PMID: 38385580

9

Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts.

Chen D, Fuda F, Rosado F, Saumell S, John S, Chen M, Koduru P, Chen W. Chen D, et al. Among authors: koduru p. Int J Lab Hematol. 2024 Jun;46(3):503-509. doi: 10.1111/ijlh.14226. Epub 2024 Jan 4. Int J Lab Hematol. 2024. PMID: 38177979

10

Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.

Kirtek T, Chen W, Laczko D, Bagg A, Koduru P, Foucar K, Venable E, Nichols M, Rogers HJ, Tam W, Orazi A, Hsi ED, Hasserjian RP, Wang SA, Arber DA, Weinberg OK. Kirtek T, et al. Among authors: koduru p. Leuk Res. 2023 Jul;130:107309. doi: 10.1016/j.leukres.2023.107309. Epub 2023 May 10. Leuk Res. 2023. PMID: 37210875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page